{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Alexandra", "organization": "", "rank": 1, "lastname": "STEVENSON"}, {"role": "reported", "firstname": "Leslie", "organization": "", "rank": 2, "lastname": "PICKER"}], "original": "By ALEXANDRA STEVENSON and LESLIE PICKER"}, "news_desk": "Business", "slideshow_credits": null, "abstract": null, "multimedia": [{"type": "image", "url": "images/2016/05/10/business/10db-ackman/10db-ackman-thumbWide.jpg", "legacy": {"wide": "images/2016/05/10/business/10db-ackman/10db-ackman-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/05/10/business/10db-ackman/10db-ackman-articleLarge.jpg", "legacy": {"xlarge": "images/2016/05/10/business/10db-ackman/10db-ackman-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "width": 600, "subtype": "xlarge", "height": 400}, {"type": "image", "url": "images/2016/05/10/business/10db-ackman/10db-ackman-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/05/10/business/10db-ackman/10db-ackman-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"main": "William Ackman Sets Out to Sell $800 Million in Shares of Zoetis"}, "print_page": null, "keywords": [{"value": "Hedge Funds", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Pershing Square Capital Management", "is_major": "N", "rank": "2", "name": "organizations"}, {"value": "Valeant Pharmaceuticals International Inc", "is_major": "N", "rank": "3", "name": "organizations"}, {"value": "Zoetis Inc", "is_major": "N", "rank": "4", "name": "organizations"}, {"value": "Ackman, William A", "is_major": "N", "rank": "5", "name": "persons"}], "snippet": "His Pershing Square Capital has had a difficult year, particularly over its stake in Valeant, the drug company that has come under intense scrutiny.", "source": "The New York Times", "lead_paragraph": "His Pershing Square Capital has had a difficult year, particularly over its stake in Valeant, the drug company that has come under intense scrutiny.", "word_count": "339", "pub_date": "2016-05-10T00:00:00Z", "subsection_name": "DealBook", "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/05/10/business/dealbook/william-ackman-sets-out-to-sell-800-million-in-shares-of-zoetis.html", "_id": "573107de38f0d81c1525b4fe"}